Literature DB >> 12890840

Do bisphosphonates make children's bones better or brittle?

Joan C Marini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12890840     DOI： 10.1056/NEJMp038103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

Authors:  Anita P Price; Sara J Abramson; Sinchun Hwang; Alexander Chou; Roger Bartolotta; Paul Meyers; Douglas S Katz
Journal:  Pediatr Radiol       Date:  2010-10-30

2.  Osteoporosis guidelines miss big picture.

Authors:  Eddie Vos
Journal:  CMAJ       Date:  2011-04-05       Impact factor: 8.262

3.  The influence of low-level laser therapy with alendronate irrigation on healing of bone defects in rats.

Authors:  Utkan Kamil Akyol; Sare Sipal; Elif Demirci; Metin Gungormus
Journal:  Lasers Med Sci       Date:  2015-02-17       Impact factor: 3.161

Review 4.  Glucocorticoid-induced osteoporosis: who to treat with what agent?

Authors:  René Rizzoli; Emmanuel Biver
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

Review 5.  Bisphosphonate therapy for osteogenesis imperfecta.

Authors:  Kerry Dwan; Carrie A Phillipi; Robert D Steiner; Donald Basel
Journal:  Cochrane Database Syst Rev       Date:  2016-10-19

6.  Severe arterial hypertension: a possible complication of McCune-Albright syndrome.

Authors:  Yasuhisa Ohata; Takehisa Yamamoto; Ikuko Mori; Toru Kikuchi; Toshimi Michigami; Yasuo Imanishi; Kenichi Satomura; Shinobu Ida; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2008-10-29       Impact factor: 3.183

7.  Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates.

Authors:  N Nicolaou; Y Agrawal; M Padman; J A Fernandes; M J Bell
Journal:  J Child Orthop       Date:  2012-01-17       Impact factor: 1.548

8.  Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy.

Authors:  Simon Waller; Tom Kurzawinski; Lewis Spitz; Rajesh Thakker; Treena Cranston; Simon Pearce; Tim Cheetham; William G van't Hoff
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

9.  Bisphosphonates in children with hypercalciuria and reduced bone mineral density.

Authors:  Michael Freundlich; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

Review 10.  Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Authors:  T M Cox; J M F G Aerts; N Belmatoug; M D Cappellini; S vom Dahl; J Goldblatt; G A Grabowski; C E M Hollak; P Hwu; M Maas; A M Martins; P K Mistry; G M Pastores; A Tylki-Szymanska; J Yee; N Weinreb
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.